CTRI/2024/03/064778尚未招募Unknown
Platelet recruitment in donors undergoing double dose plateletpheresis procedure - NI
RELIABLE CORPORATIO0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Donors who fulfil the plateletpheresis donor eligibility criteria laid down by Drugs and Cosmetic (second amendment) Rule, 2020 and consent to participate in the study
- •1. Age- 18-60 years
- •2. Weight of donor- 50 kgs and more (3)
- •3. Blood pressure-100 to 140 mm Hg systolic, 60 to 90 mm Hg diastolic with or without medication.
- •4. Pulse-60- 100/min
- •5. Temperature- Afebrile; 370C or 98.40F
- •6. Haemoglobin- 12.5 g/dl and more
- •7. Platelet count- 150,000/ul and more (3)
- •8. Donation interval- Between procedures should be at least 48 hours. A donor should not undergo the procedure more than 2 times a week or 24 times a year. After the whole blood donation plateletpheresis, the donor should be accepted only after 28 days of interval.
- •9. Skin- Free from any skin disease
- •10. Transfusion transmitted infections- Nonreactive status
- •However, for Double dose plateletpheresis procedure (DDP), the donors should fulfil the additional criteria according to Directorate General of Health Services (DGHS) 3rd edition 2022: (12)
- •1.Weight of the donor should be > 60 kgs,
- •2. Platelet count > 250 x 1011/ul,
- •3. Not a first-time donor,
- •4. Interval between two plateletpheresis procedure- at least 1 month (according to Departmental SOP)
排除标准
- •Donors who do not fulfil the plateletpheresis donor criteria laid down by the Drugs and Cosmetics (Second amendment) rules, 2020 (9) and not consent to participate in the study will be excluded.
研究者
相似试验
尚未招募
不适用
The effect of platelet release in the circulation of platelet donors undergoing platelet donation in two different platelet collection equipment.CTRI/2021/11/038233oble Diagnostics
已完成
不适用
Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic eventPatients with ACS or elective indications undergoing PCI with drug-eluting stent implantation.JPRN-UMIN000020332Toho University Ohashi Medical Center6,422
招募中
Unknown
In-house platelet transfusion from a corresponding HLA donor to an anti-HLA-antibody-positive patientJPRN-UMIN000049715St. Marianna University School of Medicine1
已完成
不适用
Coagulation improvement after platelet transfusion in critically ill patientslow platelet count10035534ThrombocytopeniaNL-OMON44365Academisch Medisch Centrum24
招募中
2 期
Investigating the Effect of Platelet-Rich Plasma in ArthroscopyIRCT20220803055610N2Tehran University of Medical Sciences20
